Infected-cell protein 27 (ICP27) is a herpes simplex virus type 1 a, or immediate-early, protein involved in the regulation of viral gene expression. To better understand the function(s) of ICP27 in infected cells, we have isolated and characterized viral recombinants containing defined alterations in the ICP27 gene. The mutant virus d27-1 contains a 1.6-kilobase deletion which removes the ICP27 gene promoter and most of the coding sequences, while n59R, n263R, n4O6R, and n5O4R are mutants containing nonsense mutations which encode ICP27 molecules truncated at their carboxyl termini. All five mutants were defective for lytic replication in Vero cells. Analysis of the mutant phenotypes suggests that ICP27 has the following regulatory effects during the viral infection: (i) stimulation of expression of fy-1 genes, (ii) induction of expression of y-2 genes, (iii) down regulation of expression of a and ,3 genes late in infection, and (iv) stimulation of viral DNA replication. Cells infected with the mutant n5O4R expressed wild-type levels of y-1 proteins but appeared to be unable to efficiently express -y-2 mRNAs or proteins. This result suggests that ICP27 mediates two distinct transactivation functions, one which stimulates y-1 gene expression and a second one required for y-2 gene induction. Analysis of the mutant n4O6R suggested that a truncated ICP27 polypeptide can interfere with the expression of many viral ,I genes. Our results demonstrate that ICP27 has a variety of positive and negative effects on the expression of viral genes during infection.
The genes of herpes simplex virus type 1 (HSV-1) are expressed in a highly ordered fashion during lytic infection, and several viral and cellular proteins involved in their regulation have been identified. Although the role of cellular proteins in this process is not well understood, the ability to isolate viral mutants has allowed detailed analyses of the functions of some of the viral regulatory proteins. Here we describe the isolation and characterization of viral mutants defective in an essential viral regulatory factor, infected-cell protein 27 (ICP27).
The 70 to 80 genes of HSV-1 are transcribed by host cell RNA polymerase II and are expressed in four sequential classes: ao, 3, -y-1, and -y-2 (for a review, see reference 50) . Transcription of the five a, or immediate-early, genes does not require viral protein synthesis but is stimulated by a protein component of the virus particle, Vmw65 (also called ICP25, a trans-inducing factor, and VP16). The next genes expressed are the P, or early, genes. Most of the a genes encode proteins involved in viral DNA replication, and viral DNA synthesis begins shortly after their expression. Soon after a gene expression, the -y-1 genes are transcribed. The expression of -y-1 genes is enhanced as viral DNA is replicated, but significant y-1 gene expression can occur prior to, or in the absence of, viral DNA replication. Finally, the -y-2 genes are expressed. The -y-2 genes are not expressed at detectable levels until after viral DNA replication.
The expression of the P and -y classes of genes requires the expression of functional ao proteins (22) . In particular, expression of the 175-kilodalton (kDa) protein ICP4 is required for transcription of P and -y genes (8, 15, 35, 51) . ICP4 is a multifunctional protein with intrinsic DNA-binding activity, but the mechanism by which it activates p and -y genes is not yet understood (24, 32, 34, 46) . The 110-kDa at protein ICPO may also play a regulatory role during lytic infection, * Corresponding author.
because viral mutants bearing deletions in the ICPO gene grow poorly, especially at low multiplicities of infection (42, 48) .
Genetic studies have indicated that a third at protein, the 63-kDa ICP27, is involved in the regulation of expression of HSV-1 genes. HSV-1 mutants with temperature-sensitive (ts) lesions in the ICP27 gene exhibit reduced expression of many y-1 genes and are unable to induce expression of -y-2 genes at the nonpermissive temperature (41) . The defects in -y gene expression are not due to defects in viral DNA replication, because the ts mutants replicate their DNA nearly as well as the wild-type (WT) virus does. Recently, a replication-defective virus bearing a deletion in the ICP27 gene was isolated and characterized (29) . Under nonpermissive conditions this mutant replicated a reduced amount of viral DNA, overexpressed certain p proteins, was defective in inducing many y-1 proteins, and failed to induce y-2 proteins.
Transient-expression experiments have also provided evidence that ICP27 modulates HSV-1 gene expression. In such experiments, reporter genes are transfected into uninfected cells together with the ICP27 gene and, in some cases, other HSV-1 regulatory genes. ICP27 can transactivate several HSV-1 promoters, including those for the alkaline exonuclease (p), glycoprotein B (gB) (p or y-1), ICP5 (-y-1), and glycoprotein C (gC) (y-2) genes (9, 39, 44, 49) . In most cases this effect requires coexpression of ICP4 and/or ICPO; however, under certain conditions ICP27 alone can transactivate the gB promoter (39) . ICP27 can also negatively affect the expression of several HSV-1 a, P, and y promoters in transfection assays (3, 44, 49) . In most cases, ICP27 has little or no effect on the basal expression of these promoters but rather acts to block the ability of a cotransfected ICP4 or ICPO gene to induce expression from the promoters. Host cell factors and other variables are likely to play a role in the response of a particular promoter to ICP27 regulation in transfected cells, because various laboratories have reported quite different effects of ICP27 on certain HSV-1 promoters.
We recently constructed four mutant plasmids that encode ICP27 molecules truncated to various extents at their carboxyl termini. The mutant genes were tested in transientexpression assays to determine the extent to which the truncated ICP27 polypeptides were able to modulate viral gene expression (40) . These experiments indicated that ICP27 possesses separable positive and negative regulatory activities. Using a similar approach, Hardwicke et al. (17) have also provided evidence that the two regulatory activities of ICP27 can be genetically separated. To see how the same mutant proteins we previously characterized affect gene expression in the context of the infected cell, we have replaced the WT gene in the viral chromosome with each of the mutant genes. In addition, we have isolated a viral mutant that bears a large deletion in the ICP27 gene and makes no detectable ICP27 mRNA or protein. The analysis of these mutants provides further evidence that ICP27 has both positive and negative effects on the expression of HSV-1 genes. Furthermore, our results indicate that ICP27 possesses two genetically separable transactivation functions. One activity stimulates, but is not required for, the expression of the fy-1 genes, while the second activity is required for expression of the -y-2 genes.
MATERIALS AND METHODS Cells, viruses, infections, and transfections. All infections and transfections were carried out in Vero or V27 cells. Vero cells were obtained from the American Type Culture Collection, Rockville, Md.; the derivation of V27 cells is described below. HSV-1 KOS1.1, originally provided by M. Levine (University of Michigan, Ann Arbor), was the WT strain used in all experiments. Infections were carried out at a multiplicity of 10 PFU per cell. Disodium phosphonoacetate (a gift from Abbott Laboratories, North Chicago, Ill.), when used, was added to the inocula and overlay media at a concentration of 400 ,ug/ml. Transfection of viral DNA for marker transfer was performed in V27 cells by using the calcium phosphate precipitation method previously described (39) .
The V27 cell line, which carries a stably integrated copy of the ICP27 gene, was isolated in the following manner. Subconfluent 100-mm-diameter dishes of Vero cells were transfected with 0.8 ,ug of pSV2neo (47), a plasmid conferring resistance to the drug G418, and either 4 or 10 ,ug of pBH27 (39), a plasmid encoding HSV-1 ICP27. Two days later, the cells were passaged 1:9 in medium containing 600
,ug of G418 per ml. G418-resistant colonies were isolated 2 to 4 weeks later and grown into mass culture. The cell lines were tested for ICP27 expression on the basis of their ability to support the plaque formation of the ICP27 mutants tsY46 (41) (Fig. 1A) . In addition, Southern analysis of viral DNA, as well as restriction analysis of the parental plasmid (designated pPsd27-lacZ1), indicated that approximately 0.8 kb had been deleted from the ICP27 gene in d27-lacZl.
Isolation of viruses carrying ICP27 deletion and nonsense mutations. Deletion and nonsense mutations in the ICP27 gene were engineered into the pPs27pdl plasmid (Fig. 1B) . The plasmids containing the 406R and 504R mutations, pPs-406R and pPs-504R, respectively, were constructed as described previously (40) . The plasmid pPsd27-1 was constructed by digesting pPs27pdl with BamHI and StuI, filling in the 3' recessed BamHI DNA ends by using the Klenow fragment of E. coli DNA polymerase, and recircularizing the large DNA fragment with DNA ligase. The plasmids pPs-59R and pPs-263R were constructed by substituting the mutant 2.4-kb BamHI-SstI fragments from the plasmids pBH-59R and pBH-263R (40) for the WT 2.4-kb BamHI-SstI fragment of pPs27pdl.
Recombinant viruses were constructed by using a marker transfer strategy. The plasmid DNAs described above were digested with PstI, individually mixed with d27-lacZ1 viral DNA, and transfected into V27 cells. The progeny viruses were harvested after 3 to 5 days and plated onto V27 cells in the presence of X-gal, as described above. Clear plaques, which were observed at frequencies of 0.5 to 5%, were picked and screened to determine whether they had acquired the ICP27 gene mutations.
Plaque isolates were screened in two ways. Plaque isolates d27-1, nS9R, and n263R were purified three times in V27 cells and then used to infect V27 cells. Crude viral DNA was prepared from the infected cells by the method of Gao and Knipe (11) . The viral DNAs were digested with XbaI and BamHI and examined by agarose gel electrophoresis for the pattern of DNA fragments diagnostic of a particular recombinant. For n406R and n504R, initial plaque isolates were used to prepare small virus stocks. These stocks were used to infect Vero cells grown on glass cover slips. The infected cells were fixed and stained for immunofluorescence by using an anti-ICP27 monoclonal antibody, H1113 (1). Because the d27-lacZl ICP27-p-galactosidase fusion protein does not react with this antibody, a positive signal was indicative of the expected recombinant. Positive isolates of n406R and n504R were then plaque purified two more times.
Large stocks of all virus mutants were prepared in V27 cells.
Characterization of viral mutants. Viral DNAs for Southern blotting were prepared as described above. Southern blotting and hybridizations were carried out by standard procedures (27) . The probe used was the plasmid pPs27pdl, which was labeled with [x-32P]dCTP by the random primer technique using the Klenow fragment of E. coli DNA polymerase (2) and random oligonucleotides (Boehringer Mannheim).
To analyze viral DNA replication, Vero cells were mockinfected or infected with various mutants. After a 1-h adsorption period, the monolayers were washed extensively with warm medium to remove unadsorbed virus. Total DNA was prepared by the method of Challberg (5) (31), containing the gene for Vmw65. To quantitate the data, the slots were cut out and the radioactivity was measured by liquid scintillation counting. For a given filter, the number of counts per minute bound to slots of mock-infected-cell DNA was averaged and the mean value was subtracted from the values obtained for the infected-cell DNA slots. For the final quantitation of the data, a slot from each dilution series was chosen that showed hybridization in the linear range of the assay (in practice, this was between 500 and 2,000 cpm hybridized). The number of counts per minute bound to this slot was multiplied by the dilution factor to derive a number, in counts per minute, which was used to quantitate the amount of HSV-1 DNA in each sample.
Western blot (immunoblot) and immunofluorescence analyses using the monoclonal antibody H1113 were carried out by methods described previously (36, 40) . For analysis of viral protein synthesis, infected cells were labeled with 15 pLCi of [35S]methionine per ml for 30 min. Harvesting of infected-cell proteins and sodium dodecyl sulfate (SDS)-gel electrophoresis in 9.25% polyacrylamide gels were performed by methods previously described (13, 26) .
Cytoplasmic RNAs for Northern (RNA) blot analysis were isolated by extraction in phenol-chloroform of the 0.5% Nonidet P-40 supernatant fractions, followed by ethanol precipitation (25) . The RNA was then suspended, digested with RNase-free DNase I (Bethesda Research Laboratories, Gaithersburg, Md.), phenol-chloroform extracted, and ethanol precipitated. Ten micrograms of each RNA sample was subjected to electrophoresis through denaturing formaldehyde-agarose gels (27) . Following electrophoresis, the RNA was transferred to GeneScreen filters (DuPont, NEN Research Products, Boston, Mass.). Hybridization of 32p_ labeled probes, radiolabeled by the random primer method, was performed by methods described previously (38) . The plasmids used for probes were pBH27 (ICP27 gene probe [39] ), pKl-2 (ICP4 gene probe [7] ), and pEcoRI-BamHI-I-I (gC gene probe [10] Insertion of the E. coli lacZ gene into the HSV-1 chromosome has been a useful tool in the isolation of viral mutants (4, 16) . Viral plaques expressing P-galactosidase, the product of the lacZ gene, can be identified on the basis of their color (blue) in the presence of X-gal, a chromogenic substrate for P-galactosidase. Our strategy was first to isolate an HSV-1 mutant expressing P-galactosidase because of an in-frame insertion of the lacZ gene into the ICP27 coding sequences. This virus could then serve as a recipient in marker transfer experiments to introduce specifically mutated ICP27 alleles into the viral genome. Recombinants containing the newly introduced ICP27 genes could be identified as clear plaques against a background of parental blue plaques.
To construct the HSV-1 lacZ insertion mutant, a recombinant plasmid was constructed in which the lacZ coding region was inserted into a deleted version of the ICP27 gene. This fusion gene was then cotransfected into V27 cells with infectious HSV-1 DNA. When the progeny viruses from this transfected culture were plated onto V27 cells in the presence of X-gal, approximately 3% of the plaques were blue. A blue plaque was picked, and the resulting virus clone was designated d27-lacZ1. Southern blot analysis indicated that d27-lacZ1 has a genomic structure consistent with the replacement of the WT ICP27 gene with the ICP27-lacZ fusion gene ( Fig. 1A ; data not shown). In addition, d27-lacZlinfected cells did not express the WT ICP27 but instead expressed a polypeptide of approximately 137 kDa, consistent with the size predicted for the ICP27-3-galactosidase fusion protein (data not shown). The stock of d27-lacZ1 virus was unable to form plaques on Vero cells (<2 x 103 PFU/ml) but formed plaques efficiently on V27 cells (2 x 108 PFU/ml).
Construction of HSV-1 mutants containing deletion or nonsense mutations in the ICP27 gene. Five plasmids were constructed which contained deletions or nonsense codon insertions in the ICP27 gene (Fig. 1B) . These plasmid DNAs were cleaved to release the viral DNA inserts and cotransfected with d27-lacZ1 DNA into V27 cells. The viral progeny from this marker transfer experiment were plated onto V27 cells in the presence of X-gal, and a fraction (approximately 1 to 5%) formed clear plaques. Viruses which formed clear plaques were isolated and screened for the presence of the newly introduced ICP27 alleles by an immunofluorescence assay or by DNA restriction analysis (see Materials and Methods for details). For each mutant, a positive plaque was purified three times and grown into a large stock in V27 cells. The potential ICP27 deletion mutant was designated d27-1. The potential nonsense codon insertion mutants were designated n59R, n263R, n406R, and n504R; the numbers in these designations correspond to the number of amino-terminal ICP27 residues expected to be present in each truncated protein. For comparison, the WT protein consists of 512 amino acid residues.
The recombinant viral genomes were characterized by Southern blot analysis to confirm that the intended mutations had been introduced into the viral genome. Viral DNA (Fig. 1A) , WT HSV-1 DNA contained two hybridizing fragments, the 6.1-kb ICP27 fragment and a 3.3-kb fragment presumably derived from the other UL-RL junction (Fig. 2) . In contrast, all five ICP27 mutant DNAs lacked the 6.1-kb fragment but contained the 3.3-kb fragment. The d27-1 DNA contained a new fragment of approximately 4.6 kb, consistent with its expected 1.6-kb deletion. The four remaining mutant DNAs all contained two new bands, the sizes of which added up to approximately 6.1 kb, consistent with the insertion of an XbaI site at the expected position in each mutant genome. Furthermore, none of the mutant genomes contained the 8.4-kb PstI fragment, which would be expected for the d27-lacZ1 parental DNA (Fig.  1A) .
Plaque assays were performed to determine whether the mutants were able to grow in Vero cells, a cell line used routinely for growth of HSV-1. All five mutants were unable to form plaques on Vero cells at the lowest dilution which (30) .
We previously used immunofluorescence microscopy to examine the intracellular localization of the 263R, 406R, and 504R polypeptides when they were expressed from plasmids in transfected cells (40) . All three mutant polypeptides localized to the cell nucleus but differed in their patterns of intranuclear accumulation. Thus, it was of interest to determine the intracellular distribution of the mutant proteins when they were expressed in infected cells. At 4 h p.i., infected Vero cells were fixed and processed for immunofluorescence microscopy using the monoclonal antibody H1113. Cells infected with the WT virus showed nuclear staining ( Fig. 4C and D) (Fig. 4E and F) . However, in this case these areas appeared by phase-contrast microscopy to correspond to nucleoli. Cells infected with n406R also showed nuclear staining, but the pattern of staining differed from that of WT virusinfected cells in two respects (Fig. 4G and H) in infected cells, a quantity determined by the rate of DNA synthesis as well as by the stability of the replicated DNA.
Patterns of viral protein synthesis in ICP27 mutant-infected cells. To determine the effect of the ICP27 defects on viral gene expression, we analyzed viral protein synthesis in mutant virus-infected cells. Mock-or HSV-1-infected Vero cells were pulse-labeled with [35S]methionine at 3, 6, or 9 h p.i. The labeled proteins were separated by SDS-PAGE and visualized by autoradiography (Fig. 6) . With the exception of n406R, the ICP27 gene mutants at 3 and 6 h p.i. showed patterns of protein synthesis that were qualitatively similar to the WT pattern. The mutant n406R, however, failed to fully induce the synthesis of several proteins, including ICP6, ICP8, and the precursor to gB (pgB).
At 9 h p.i., however, all five ICP27 mutants showed both quantitative and qualitative differences in viral protein synthesis compared with the WT. The five mutants fell into four phenotypic classes with respect to viral protein synthesis at late times. The phenotypes of d27-1 and n59R were indistinguishable in this experiment and in several repeat experiments. Both of these mutants expressed high levels of most defects in protein synthesis observed in Vero cells are in fact due to defects in the ICP27 gene and not due to any potential secondary mutations which map outside of the ICP27 gene. Accumulation of viral mRNAs in ICP27 mutant-infected cells. The experiments described above indicated that all five ICP27 mutants were defective for both the down regulation of the a protein ICP4 and the induction of y-2 proteins. In addition, the phenotype of the mutant n504R suggested that ICP27 may act to negatively regulate its own expression. To address the mechanisms by which ICP27 affects the expression of the ICP4, ICP27, and y-2 genes, we measured the steady-state level of viral mRNAs by Northern blot analysis. Vero cells were mock-infected or infected with WT virus, n59R, d27-1, or n504R. The WT virus infections were carried out in the presence or absence of phosphonoacetic acid (PAA), a specific inhibitor of HSV-1 viral DNA synthesis. Cytoplasmic RNA was isolated from the infected cells at 9 h p.i. Equal amounts of RNA were subjected to electrophoresis in formaldehyde-agarose gels and transferred to nylon filters. The filters were probed with radiolabeled DNAs specific for the ICP27 (Fig. 8A), ICP4 (Fig. 8B), or gC (Fig.  8C) mRNA.
No ICP27-specific mRNAs were detected in mock-or d27-1-infected cells (Fig. 8A, lanes 2 and 3) . The latter result was expected because the deletion in d27-1 removes the ICP27 gene promoter as well as 80% of the coding region.
RNA isolated from n59R-or n504R-infected cells (Fig. 8A,  lanes 4 and 5) contained two-to threefold more 2.0-kb ICP27 mRNA than did RNA from WT virus-infected cells (Fig. 8A,  lane 6) , as shown by densitometric analysis of the autoradiograms. This result was qualitatively consistent with the elevated levels of ICP27 protein synthesis observed at 9 h p.i. in n504R-infected cells. In addition, several minor mRNAs hybridizing to the ICP27 probe differed between the WT virus infections and the infections involving the mutant, but the origin of these transcripts was not investigated further.
In contrast to the results obtained with the ICP27 mRNAs, approximately equal amounts of ICP4 mRNA were observed in d27-1-, n59R-, and WT virus-infected cells (Fig. 8B, lanes  3, 4, and 6 ), whereas n504R-infected cells accumulated only 1.6-fold more ICP4 mRNA than did WT virus-infected cells (Fig. 8B, lanes 5 and 6) , as measured by densitometric analysis. These results were somewhat unexpected because little or no ICP4 protein synthesis was detected at 9 h p.i. in WT virus-infected cells, but ICP4 synthesis was readily detected in cells infected with the ICP27 gene mutants (Fig.  6, 9 h p.i.) . Therefore, the level of ICP4 protein synthesis occurring at 9 h p.i. in the various infections did not reflect the level of cytoplasmic ICP4 transcripts. These results suggest that ICP4 mRNAs are translated more efficiently in cells infected with ICP27 gene mutants than in cells infected with the WT virus.
We next examined the cytoplasmic accumulation of mRNA transcribed from a well-characterized -y-2 gene encoding gC (10, 21) . As expected, inhibition of DNA replication by PAA drastically reduced the amount of gC mRNA which accumulated during the WT virus infection (Fig. 8C , lanes 1 and 6; gC mRNA could be detected in lane 1 upon longer exposures of the autoradiogram). Neither d27-1-, n59R-, nor n504R-infected cells expressed readily detectable levels of gC mRNA (Fig. 8C, lanes 3, 4, and 5, respectively) . This is of particular interest in the case of the mutant n504R, which replicated WT levels of DNA during infection. These results suggest that the expression of -y-2 genes requires both the replication of the viral DNA and a virus-encoded transacting factor, ICP27. The comparison of the phenotypes of the viral mutants carrying nonsense mutations with the WT and null phenotypes has allowed us to define the following regulatory effects of ICP27: (i) stimulation of -y-1 gene expression, (ii) induction of y-2 gene expression, (iii) negative regulation of the expression of certain a and genes, and (iv) stimulation of viral DNA replication. As we discuss below, our results demonstrate that certain of these activities are genetically separable.
Stimulation of y-1 gene expression by ICP27. Cells infected with the ICP27 null mutant, d27-1, were unable to fully activate expression of most -y-1 genes. Thus, ICP27 carries out an activity in infected cells that enhances y-1 gene expression. Amino-terminal portions of ICP27 appeared to be able to partially induce -y-1 gene expression, because n263R-and n406R-infected cells synthesized more of several y-1 proteins, such as ICP5, late in infection than did d27-1-or n59R-infected cells. However, the mutants n263R and n4O6R did not appear to replicate significantly more viral DNA over the course of infection than either d27-1 or n59R. Therefore, the increase in the expression of the -y-1 proteins appears to be due to an effect of ICP27 on -y-1 gene expression other than stimulation of viral DNA replication. The mutant n504R expressed WT levels of -y-1 proteins. However, because this mutant replicated more viral DNA than did n4O6R, it is not clear whether the increased expression of -y-1 genes is due to an increased transactivation function of the n5O4R polypeptide or due to increased levels of viral DNA replication.
The mechanism by which ICP27 stimulates expression of the y-1 genes is not known. It is worth noting that when Previous studies have implicated ICP4 in the activation of y-2 genes, most likely at the level of transcription (6, 8, 51) .
In addition to ICP27 and ICP4, the expression of the -y-2 mRNAs requires replication of the viral DNA template (14, 18, 20, 23 Our results indicate that amino acid residues 407 to 504 of ICP27 are critical for this function because the n406R mutant is deficient for viral DNA replication while the n504R mutant is not. The mutants n263R and n406R did not appear to replicate significantly more viral DNA than did d27-1, but they did express detectably more y-1 proteins. Thus, we favor the idea that these two functions of ICP27, i.e., its ability to stimulate fy-1 gene expression and its ability to stimulate viral DNA replication, are genetically separable. However, further experiments are required to prove this point conclusively.
Regulation of the gB gene. A possible exception to our generalizations concerning the response of HSV-1 genes to ICP27 is the gB gene. The generalizations hold true if the gB gene is considered to be a 13 gene rather than a y-1 gene.
VOL. 64, 1990 However, various studies have described it as either a (19, 37) or a -y-1 (21, 52) (17) , have begun to localize the functional regions of the polypeptide, but much work needs to be done. The genetic system we describe here can be used to isolate a large number of viral mutants encdding specifically altered forms of ICP27. The characterization of such mutants should provide a useful approach both for mechanistic studies of ICP27 and for the detailed mapping of its functional domains.
